ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study

Abstract Background Sarcoid tumors are common in horses and may negatively impact the performance and value of the horse. No known treatment is reliably successful. Hypotheses/Objectives To determine tolerability, overall response rate, time to response, and progression‐free survival of horses with...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Corey Saba, Randall Eggleston, Andrew Parks, John Peroni, Eric Sjoberg, Shelbe Rice, Jesse Tyma, Jarred Williams, Deborah Grosenbaugh, A. Timothy Leard
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2022-05-01
coleção:	Journal of Veterinary Internal Medicine
Assuntos:	equine immunotherapy sarcoid treatment
Acesso em linha:	https://doi.org/10.1111/jvim.16425
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!